BCX 4430 3022 13 mg/mL(50 mM)

13 mg/mL(50 mM)

59(1):289-98

CHR-2797 is converted into a pharmacologically active acid product (CHR-79888) inside cells

IWP-4 also causes a significant down regulation of SPARC and COL1A1

In platelet physiological responses

BCX 4430 3022 13 mg/mL(50 mM)Galidesivir, also known as BCX4430 and Immucillin A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses,